Aurinia Pharmaceuticals Inc. (AUPH) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aurinia Pharmaceuticals Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 7.46x | 223.34x | -16.50x | -5.67x | -16.35x | -15.96x |
| P/B Ratio | 3.69x | 3.40x | 3.41x | 1.51x | 6.18x | 4.02x |
| P/S Ratio | 7.57x | 5.46x | 7.34x | 4.57x | 64.88x | 32.69x |
| Profitability | ||||||
| Gross Margin | 88.5% | 88.0% | 91.9% | 95.8% | 97.6% | 100.0% |
| Operating Margin | 37.1% | -2.0% | -52.2% | -83.2% | -396.3% | -208.1% |
| Net Margin | 101.5% | 2.4% | -44.5% | -80.7% | -396.8% | -204.9% |
| EBITDA Margin | 45.1% | 13.5% | -35.9% | -77.3% | -389.1% | -205.4% |
| Liquidity | ||||||
| Current Ratio | 5.25x | 4.57x | 5.50x | 9.60x | 12.63x | 13.11x |
| Quick Ratio | 4.76x | 4.17x | 4.99x | 9.06x | 12.15x | 12.67x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 0.21x | 0.26x | 0.02x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..